{"id":989776,"date":[{"year":1995,"month":5,"day":26}],"page":"4","source":"本报","region":"北京","masthead":"国内新闻","special_issue":"","column":"","genre":"","count":"208","ytitle":"","mtitle":"注射用促肝细胞生长素试生产","ftitle":"","authors":["王捷南"],"text":[{"type":"paragraph","text":"本报北京5月25日专电　(驻京记者　王捷南)中国科学院院士、南京大学校长曲钦岳今天在北京宣布:经过南京大学、解放军第八一医院多年的联合攻关，注射用促肝细胞生长素(CHGF)已获得国家卫生部颁发的国家一类新药证书，并由南大制药厂投入批量试生产供应临床。"},{"type":"paragraph","text":"据介绍，此药能够有效阻止肝细胞坏死、促进肝细胞再生，为各类重型肝炎和有发展为重型肝炎趋势的慢性活动性肝炎患者提供了最新的治疗途径。"}]}